Pr Patrice Carde has over 40 years of clinical Onco-Hematology experience, former Chef de Service at Gustave Roussy Cancer Campus & former Chairman of the EORTC Lymphoma Group. He conducted Oncology trials aiming at optimpal ratio between effective tumor control and minimal long-term toxicities.
Currently at Gustave Roussy Cancer Campus, American Hospital of Paris and Clinque Hartmann, as a clinician.
Dr Eric Jeandidier has over 20 years of clinical cytogenetics experience, chef de service of genetics at Hôpital Emile Muller GHR Mulhouse et Sud-Alsace and member of francophone hematology cytogenetic society and european cytogeneticists association. He had an MD from the University of Strasbourg. He has a particular expertise in the field of chromosomal aberration detection.
Dr M’kacher has worked in the field of chromosomal aberrations and telomere dysfunction in response to genotoxic stress for more 20 years. By combining molecular and cellular approaches with advanced microscopy techniques, her research is focused to identify new biomarker involved in formation of chromosomal aberrations and their functional relevance for the maintenance of genome integrity in response to DNA damage. She began her career in Gustave Roussy Cancer Campus in the introduction of cytogenetic biological dosimetry in nuclear medicine. In the Hematology department, she was promoted the predictive and prognostic factors in the occurrence of secondary cancer. In 2010, she joined commissariat of atomic energy (CEA), to participate in European project in low-dose radiation. Significant progress was made in telomere length quantification, telomere dysfunction and the mechanisms underlying the formation of chromosomal aberration. Dr. M’kacher earned her PhD in the field of radiobiology in the domain of populations exposed to genotoxic agents and her HDR at the University of Paris-Saclay.
Dr Theodore Girinsky has over 40 years radiation therapy experience, former Chef de unite at Gustave Roussy Cancer Campus & former Chairman of the EORTC Lymphoma Group. He conducted radiation oncology trials aiming at optimal ratio between efficacity of the treatment and side effects.
Dr Bruno Colicchio received his Ph.D. degree in Science from University of Haute-Alsace (UHA) in year 2004, Mulhouse, France.He is currently associate professor since 2005 at University of Haute-Alsace, and member of IRIMAS (Institut de recherche en informatique, mathématiques, et en automatique et signal).His research interests include image formation process, plenoptic cameras, time frequency analysis, image and signal processing and inverse problems.
Dr Philippe Voisin has worked in the field of biological dosimetry and dose assessement after exposure to ionizing radiation. During his career, he has held various academic and institutionelle position. He has over 30 years of radiation protection experience, former chef of department of the Radiation Biology & Epidemiology Department; Institut de Radioprotection et Sûreté Nucléaire biological dosimetry (IRSN) fontenay aux roses.